Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride.
Campodónico DM, Zubiaur P, Soria-Chacartegui P, Casajús A, Villapalos-García G, Navares-Gómez M, Gómez-Fernández A, Parra-Garcés R, Mejía-Abril G, Román M, Martín-Vílchez S, Ochoa D, Abad-Santos F. Campodónico DM, et al. Clin Transl Sci. 2022 Nov;15(11):2613-2624. doi: 10.1111/cts.13386. Epub 2022 Sep 6. Clin Transl Sci. 2022. PMID: 36065758 Free PMC article. Clinical Trial.
Genotype-Guided Prescription of Azathioprine Reduces the Incidence of Adverse Drug Reactions in TPMT Intermediate Metabolizers to a Similar Incidence as Normal Metabolizers.
Casajús A, Zubiaur P, Méndez M, Campodónico D, Gómez A, Navares-Gómez M, Villapalos-García G, Soria-Chacartegui P, Novalbos J, Román M, Mejía-Abril G, Ochoa D, Abad-Santos F. Casajús A, et al. Adv Ther. 2022 Apr;39(4):1743-1753. doi: 10.1007/s12325-022-02067-8. Epub 2022 Feb 22. Adv Ther. 2022. PMID: 35192152 Free PMC article.
NAT2 phenotype alters pharmacokinetics of rivaroxaban in healthy volunteers.
Villapalos-García G, Zubiaur P, Ochoa D, Soria-Chacartegui P, Navares-Gómez M, Matas M, Mejía-Abril G, Casajús-Rey A, Campodónico D, Román M, Martín-Vílchez S, Candau-Ramos C, Aldama-Martín M, Abad-Santos F. Villapalos-García G, et al. Biomed Pharmacother. 2023 Sep;165:115058. doi: 10.1016/j.biopha.2023.115058. Epub 2023 Jun 28. Biomed Pharmacother. 2023. PMID: 37385211 Free article.
The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study).
Sancho-López A, Ruiz-Antorán B, Hernangómez TI, Ramírez-García A, Gómez-Estévez I, Sanabria-Cabrera J, Llop Rius R, Pedrós C, Campodonico D, Jiménez-Jorge S, García Luque A, Costa Frossad França L, Montané E, Aldea-Perona A, Téllez Lara N, Bosch Ferrer M, Rodriguez Jiménez C, Bonilla-Toyos E, Sabín Muñoz J, Avendaño-Solá C, Blasco Quilez MR, On Behalf Of The Realhes-Study Group. Sancho-López A, et al. J Clin Med. 2023 Oct 11;12(20):6471. doi: 10.3390/jcm12206471. J Clin Med. 2023. PMID: 37892611 Free PMC article.